InvestorsHub Logo
Followers 53
Posts 3355
Boards Moderated 0
Alias Born 10/26/2013

Re: AVII77 post# 2002

Thursday, 12/21/2017 1:54:06 PM

Thursday, December 21, 2017 1:54:06 PM

Post# of 3283
That is so strange of an occurrence. I wasn't worried about pozi. Thankfully, I was thinking that the MDA trial did it's job gathering enough data, once it matures some, for breakthrough designation. What I felt about about was there wasn't an avenue for 1st line EGFR Exon 20 mutation pts to get pozi since the SPPI trial is excluding them right now.